Fjarde Ap-fonden’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.38M | Sell |
27,647
-6,200
| -18% | -$544K | 0.01% | 469 |
|
|
2026
Q1 | $3.06M | Buy |
33,847
+10,300
| +44% | +$945K | 0.02% | 481 |
|
|
2025
Q4 | $2.12M | Sell |
23,547
-300
| -1% | -$28.4K | 0.02% | 454 |
|
|
2025
Q3 | $2.35M | Sell |
23,847
-3,500
| -13% | -$347K | 0.02% | 411 |
|
|
2025
Q2 | $2.49M | Buy |
27,347
+3,000
| +12% | +$290K | 0.02% | 431 |
|
|
2025
Q1 | $2.76M | Sell |
24,347
-10,100
| -29% | -$1.08M | 0.03% | 405 |
|
|
2024
Q4 | $3.64M | Buy |
34,447
+5,000
| +17% | +$536K | 0.04% | 396 |
|
|
2024
Q3 | $3.18M | Buy |
+29,447
| New | +$3.21M | 0.03% | 427 |
|
|
2024
Q1 | $4.48M | Sell |
33,947
-500
| -1% | -$62.5K | 0.05% | 373 |
|
|
2023
Q4 | $4.19M | Sell |
34,447
-6,069
| -15% | -$677K | 0.05% | 366 |
|
|
2023
Q3 | $4.55M | Buy |
40,516
+2,200
| +6% | +$279K | 0.06% | 332 |
|
|
2023
Q2 | $5.58M | Sell |
38,316
-6,000
| -14% | -$815K | 0.07% | 296 |
|
|
2023
Q1 | $5.73M | Sell |
44,316
-8,000
| -15% | -$1M | 0.08% | 284 |
|
|
2022
Q4 | $6.67M | Sell |
52,316
-5,000
| -9% | -$580K | 0.09% | 239 |
|
|
2022
Q3 | $6.02M | Hold |
57,316
| – | – | 0.08% | 275 |
|
|
2022
Q2 | $6.02M | Sell |
57,316
-1,900
| -3% | -$225K | 0.08% | 275 |
|
|
2022
Q1 | $7.57M | Sell |
59,216
-12,488
| -17% | -$1.51M | 0.07% | 280 |
|
|
2021
Q4 | $8.84M | Buy |
71,704
+721
| +1% | +$94.4K | 0.08% | 271 |
|
|
2021
Q3 | $10.1M | Sell |
70,983
-2,678
| -4% | -$394K | 0.09% | 215 |
|
|
2021
Q2 | $11.5M | Buy |
73,661
+515
| +0.7% | +$83.4K | 0.11% | 193 |
|
|
2021
Q1 | $11.4M | Buy |
73,146
+927
| +1% | +$144K | 0.1% | 197 |
|
|
2020
Q4 | $10.8M | Buy |
72,219
+5,871
| +9% | +$829K | 0.1% | 192 |
|
|
2020
Q3 | $8.77M | Buy |
66,348
+2,884
| +5% | +$377K | 0.1% | 200 |
|
|
2020
Q2 | $7.35M | Buy |
63,464
+2,399
| +4% | +$276K | 0.09% | 223 |
|
|
2020
Q1 | $5.99M | Sell |
61,065
-4,223
| -6% | -$554K | 0.1% | 202 |
|
|
2019
Q4 | $9.49M | Buy |
65,288
+4,738
| +8% | +$654K | 0.12% | 177 |
|
|
2019
Q3 | $8.07M | Buy |
60,550
+2,060
| +4% | +$266K | 0.11% | 214 |
|
|
2019
Q2 | $6.69M | Sell |
58,490
-5,974
| -9% | -$700K | 0.09% | 261 |
|
|
2019
Q1 | $7.99M | Buy |
64,464
+13,754
| +27% | +$1.56M | 0.1% | 220 |
|
|
2018
Q4 | $5.11M | Sell |
50,710
-6,592
| -12% | -$741K | 0.09% | 237 |
|
|
2018
Q3 | $7.31M | Sell |
57,302
-2,678
| -4% | -$318K | 0.11% | 205 |
|
|
2018
Q2 | $6.49M | Sell |
59,980
-655
| -1% | -$71.3K | 0.1% | 226 |
|
|
2018
Q1 | $6.42M | Buy |
60,635
+34
| +0.1% | +$3.95K | 0.1% | 221 |
|
|
2017
Q4 | $7.1M | Buy |
60,601
+9,252
| +18% | +$1.05M | 0.11% | 208 |
|
|
2017
Q3 | $5.84M | Buy |
51,349
+2,698
| +6% | +$311K | 0.11% | 201 |
|
|
2017
Q2 | $6.07M | Buy |
48,651
+6,798
| +16% | +$806K | 0.12% | 186 |
|
|
2017
Q1 | $4.96M | Sell |
41,853
-2,734
| -6% | -$310K | 0.12% | 200 |
|
|
2016
Q4 | $4.47M | Sell |
44,587
-4,485
| -9% | -$481K | 0.1% | 218 |
|
|
2016
Q3 | $6.2M | Buy |
49,072
+3,230
| +7% | +$399K | 0.14% | 170 |
|
|
2016
Q2 | $5.36M | Buy |
45,842
+394
| +0.9% | +$44.6K | 0.12% | 191 |
|
|
2016
Q1 | $4.71M | Buy |
45,448
+10,093
| +29% | +$976K | 0.11% | 212 |
|
|
2015
Q4 | $3.53M | Buy |
35,355
+719
| +2% | +$70.3K | 0.09% | 247 |
|
|
2015
Q3 | $3.17M | Sell |
34,636
-2,486
| -7% | -$249K | 0.09% | 259 |
|
|
2015
Q2 | $3.94M | Sell |
37,122
-2,185
| -6% | -$242K | 0.1% | 245 |
|
|
2015
Q1 | $4.49M | Sell |
39,307
-1,746
| -4% | -$199K | 0.1% | 232 |
|
|
2014
Q4 | $4.53M | Sell |
41,053
-3,675
| -8% | -$387K | 0.1% | 246 |
|
|
2014
Q3 | $4.38M | Sell |
44,728
-3,752
| -8% | -$369K | 0.09% | 246 |
|
|
2014
Q2 | $4.9M | Sell |
48,480
-1,794
| -4% | -$175K | 0.1% | 241 |
|
|
2014
Q1 | $4.63M | Buy |
50,274
+3,421
| +7% | +$315K | 0.09% | 253 |
|
|
2013
Q4 | $4.25M | Sell |
46,853
-3,776
| -7% | -$327K | 0.09% | 268 |
|
|
2013
Q3 | $4.05M | Sell |
50,629
-3,535
| -7% | -$278K | 0.09% | 276 |
|
|
2013
Q2 | $3.95M | Buy |
+54,164
| New | +$4.05M | 0.08% | 289 |
|
Other funds holding ZBH
Fjarde Ap-fonden's ZBH Position: Q2 2026 in Review
Fjarde Ap-fonden reduced its Zimmer Biomet (ZBH) stake by 18% in Q2 2026, selling an estimated $544K and leaving 27,647 shares worth $2.38M. The position accounts for 0.01% of the portfolio, ranked #469.
Fjarde Ap-fonden first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.5M in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Fjarde Ap-fonden held 27,647 shares of Zimmer Biomet worth $2.38M as of Q2 2026.
- Fjarde Ap-fonden sold 6,200 Zimmer Biomet shares in Q2 2026, an estimated $544K.
- Zimmer Biomet made up 0.01% of Fjarde Ap-fonden's portfolio in Q2 2026, its #469 holding.
- Fjarde Ap-fonden first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Fjarde Ap-fonden's Zimmer Biomet position peaked at $11.5M in Q2 2021.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.